Stock search

Ticker or company name

Compare stocks

Market: US

  • DGXQuest Diagnostics
  • DXCMDexcom
  • LHLabcorp

Add stock

Ticker or company

Summary

DGX
Quest Diagnostics
$262,21Up +1,01%
Year: Up +38%
61/100Ratio would watch
Open stock page
DXCM
Dexcom
$81,61Down −2,06%
Year: Up +40%
89/100Best scoreRatio would consider buying
Open stock page
LH
Labcorp
$372,46Up +0,53%
Year: Up +38%
56/100Ratio would watch
Open stock page

Verdict

DXCM has the best score (89). DXCM grows revenue the fastest. LH is the cheapest by forward P/E. DXCM has the lowest debt load. DXCM has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckDGX3 ✓ 5 — 1 ✕DXCM8 ✓ 0 — 1 ✕LH3 ✓ 4 — 2 ✕
P/E vs its history25,531,430,0
P/E vs industry25,531,430,0
Forward P/E21,326,818,6
Revenue growth, YoY+9,1%+13,0%+6,0%
EPS growth, YoY+17,8%+41,1%+19,6%
Net margin9,5%19,4%6,9%
Net debt / EBITDA2,1−0,62,3
Free cash flow$1,38 bn$1,10 bn$1,29 bn
Share count over a year−0,9%−5,9%−2,5%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterDGXTTMDXCMTTMLHTTMIndustry medianTTM
P/E TTM ↓Best: 25,5Worst: 31,430,025,1
Forward P/E ↓21,3Worst: 26,8Best: 18,616,2
PEG ↓2,6Best: 1,4Worst: 3,22,2
P/S TTM ↓2,4Worst: 6,1Best: 2,12,2
EV/EBITDA ↓Best: 17,9Worst: 21,019,817,3
P/FCF ↓Best: 20,9Worst: 28,323,419,5

Price, %

  • DGXn/a
  • DXCMn/a
  • LHn/a

Returns

Best WorstNo mark — in between

PeriodDGXDXCMLH
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

DGXDXCMLH
Share of “buy”Worst: 52%Best: 89%78%
Beat the forecastBest: 4 of 4Worst: 3 of 4Worst: 3 of 4
Average “surprise”Best: +5,0%+0,9%Worst: +0,6%
Insiders over 12 monthssales $45,8 msales $12,2 msales $11,7 m

Details are on each stock page.